サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566954

閉鎖系薬剤移送装置市場：タイプ別、コンポーネント別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Closed System Drug Transfer Device Market By Type , By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 216 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
閉鎖系薬剤移送装置市場：タイプ別、コンポーネント別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 216 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

閉鎖系薬剤移送装置（CSTD）市場

閉鎖系薬剤移送装置（CSTD）市場は、2023年に8億米ドルと評価され、2024年から2033年にかけてCAGR 15.7%で成長し、2033年には36億米ドルに達すると予測されています。

閉鎖系薬剤移送装置（CSTD）は、システムの内部環境と外部環境との接触を防ぐ医療機器です。CSTDは、周囲から医療機器やシステムへの汚染物質の侵入を防ぎ、システムから外部環境への危険な化学物質や蒸気の回避を禁止します。これらのデバイスは、細胞毒性や催奇形性を持つ可能性の高い薬剤から、患者と病院内で働く医療従事者の安全を守るために非常に重要です。

がんやその他の慢性疾患の有病率の増加に伴い、CSTDの採用はほとんどのヘルスケア環境で不可欠となっており、市場の成長を牽引しています。さらに、労働安全衛生局や米国薬局方など、複数の管理機関による規制の実施がCSTDの需要を押し上げています。CSTDとオートメーションおよびロボット工学の統合は、薬局や調剤施設において、危険化学物質の効率的な取り扱いと使用を保証するために大きな注目を集める動向です。

しかし、多様なサイズのシリンジ、薬剤バイアル、輸液システムとCSTDの互換性に関連する技術的なハードルは、誤作動のリスクをもたらし、閉鎖系薬剤移送装置（CSTD）市場の開拓を妨げています。さらに、CSTDの使用には高い熟練度と専門的なトレーニングが必要であり、通常、資源集約的で手間がかかります。これが市場成長の妨げとなっています。これとは対照的に、がん患者の急激な増加は市場に有利な成長機会をもたらすと予想されます。がん患者数は2040年までに年間3,000万人のペースで増加すると予想されており、病院でのCSTD使用が必要となっています。

セグメント別レビュー

閉鎖系薬剤移送装置（CSTD）市場は、タイプ、コンポーネント、エンドユーザー、地域に区分されます。タイプ別では、市場はメンブレンtoメンブレンとニードルレスに二分されます。コンポーネント別では、バリアタイプCSTDと空気清浄CSTDに分けられます。エンドユーザー別では、病院・クリニック、腫瘍センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

タイプ別では、メンブレンtoメンブレンセグメントが閉鎖系薬剤移送装置（CSTD）市場を独占しています。

エンドユーザー別では、病院・クリニック向けが高いシェアを占めています。

地域別では、北米が閉鎖系薬剤移送装置（CSTD）市場の主要な収益源です。

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた追加企業プロファイル
  • 平均販売価格分析/ 価格帯分析
  • 過去の市場データ
  • 償還シナリオ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 閉鎖系薬剤移送装置（CSTD）市場：タイプ別

  • 市場概要
  • メンブレン・ツー・メンブレン
  • ニードルレス

第5章 閉鎖系薬剤移送装置（CSTD）市場：コンポーネント別

  • 市場概要
  • バリアタイプCSTD
  • 空気清浄CSTD

第6章 閉鎖系薬剤移送装置（CSTD）市場：エンドユーザー別

  • 市場概要
  • 病院および診療所
  • 腫瘍センター
  • その他

第7章 閉鎖系薬物移送装置（CSTD）市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の閉鎖系薬物移送装置（CSTD）市場
    • カナダの閉鎖系薬物移送装置（CSTD）市場
    • メキシコの閉鎖系薬剤移送装置（CSTD）市場
  • 欧州
    • 主な市場動向と機会
    • フランスの閉鎖系薬剤移送装置（CSTD）市場
    • ドイツの閉鎖系薬剤移送装置（CSTD）市場
    • イタリアの閉鎖系薬剤移送装置（CSTD）市場
    • スペインの閉鎖系薬剤移送装置（CSTD）市場
    • 英国の閉鎖系薬剤移送装置（CSTD）市場
    • その他欧州の閉鎖系薬剤移送装置（CSTD）市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の閉鎖系薬剤移送装置（CSTD）市場
    • 日本の閉鎖系薬剤移送装置（CSTD）市場
    • インドの閉鎖系薬物移送装置（CSTD）市場
    • 韓国の閉鎖系薬剤移送装置（CSTD）市場
    • オーストラリアの閉鎖型薬物移送装置（CSTD）市場
    • その他アジア太平洋の閉鎖型薬物移送装置（CSTD）市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの閉鎖系薬剤移送装置（CSTD）市場
    • 南アフリカ閉鎖系薬剤移送装置（CSTD）市場
    • サウジアラビアの閉鎖系薬剤移送装置（CSTD）市場
    • その他のラテンアメリカ・中東・アフリカの閉鎖系薬剤移送装置（CSTD）市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • B. Braun Holding GmbH And Co. KG
  • Baxter International
  • Becton, Dickinson And Company
  • Caragen Ltd.
  • Corvida Medical
  • Equashield
  • FIMI Opportunity Funds（Simplivia Healthcare）
  • ICU Medical
  • JCB Co Ltd.
  • Yukon Medical
目次
Product Code: A324072

Closed System Drug Transfer Device (CSTD) Market

The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.

With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.

However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.

Segment Review

The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.

Competition Analysis

The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Average Selling Price Analysis / Price Point Analysis
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Barrier type CSTDs
  • Air cleaning CSTDs

By End User

  • Hospitals and Clinics
  • Oncology Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

By Type

  • Membrane to membrane
  • Needleless

Key Market Players:

    • B. Braun Holding GmbH & Co. KG
    • Baxter International
    • Becton, Dickinson and Company
    • Caragen Ltd.
    • Corvida Medical
    • Equashield
    • FIMI Opportunity Funds (Simplivia Healthcare)
    • ICU Medical
    • JCB Co Ltd.
    • Yukon Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Membrane To Membrane
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Needleless
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Barrier Type CSTDs
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Air Cleaning CSTDs
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Closed System Drug Transfer Device (CSTD) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Closed System Drug Transfer Device (CSTD) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Closed System Drug Transfer Device (CSTD) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. B. Braun Holding GmbH And Co. KG
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Becton, Dickinson And Company
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Caragen Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Corvida Medical
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Equashield
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. FIMI Opportunity Funds (Simplivia Healthcare)
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. ICU Medical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. JCB Co Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Yukon Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments